Chronic School Absenteeism 5.8 Percent for 5- to 17-Year-Olds in 2022
By Elana Gotkine HealthDay Reporter
THURSDAY, March 14, 2024 -- In 2022, 5.8 percent of children ages 5 to 17 years experienced chronic school absenteeism for health-related reasons, according to a March data brief published by the National Center for Health Statistics.
Lindsey I. Black, M.P.H., and Nazik Elgaddal, from the National Center for Health Statistics in Hyattsville, Maryland, describe the percentage of children ages 5 to 17 years who experienced chronic school absenteeism due to illness, injury, or disability using data from the 2022 National Health Interview Survey.
The researchers found that in 2022, in the past 12 months, 5.8 percent of children ages 5 to 17 years experienced chronic school absenteeism for health-related reasons. There was variation observed in the percentage of children who experienced chronic absenteeism by race and Hispanic origin. The likelihood of experiencing chronic school absenteeism was increased for children with family incomes of less than 200 percent of the federal poverty level versus those with family incomes of 200 percent of the federal poverty level or more. The likelihood of experiencing chronic school absenteeism was about three times higher for children with versus those without disabilities (14.8 and 4.4 percent, respectively).
"In 2022, 5.8 percent of children experienced chronic school absenteeism for health-related reasons in the past 12 months. Differences by sex and age were not significant," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted March 2024
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.